Medicinal Mushroom Compounds Act on Key Disease Receptors

Reishi, Cordyceps, Chaga

What they found

A review shows compounds in reishi, cordyceps and chaga interact with receptors involved in inflammation, cancer, diabetes and brain conditions.

How solid is it?

Review

Narrative review

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Ganoderma lucidum, Cordyceps sinensis, Inonotus obliquus

Published in

eprint.innovativepublication.org

Covered in Shroom Scan

Jul 4, 2025

Section

HEALTH & WELLNESS

As it ran in Shroom Scan

Fungal Potential

Medicinal mushrooms like reishi (Ganoderma lucidum), cordyceps (Cordyceps sinensis), and chaga (Inonotus obliquus) contain bioactive compounds that target human receptors linked to major diseases. This review shows how fungal compounds interact with pathways involved in inflammation, cancer, diabetes, and neurological conditions—mimicking drugs that act on serotonin, opioid, COX-2, and VEGF receptors. It offers a roadmap for discovering new medicines from fungi.

Reishi Shrinks Tumors, Psilocybin Eases Anxiety, and a Free Gift Inside

Read the original study ↗

Get Shroom Scan

Next study

African Oyster Mushroom Extract Calms and Prevents Seizures in Mice ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →